TROPiCS-02 Final Analysis
TROPiCS-02: Final OS Analysis of the Phase III Trial of Sacituzumab Govitecan vs Treatment of Physician’s Choice in HR+/HER2- Advanced Breast Cancer

Released: June 13, 2023

Activity

Progress
1
Course Completed